Novo Nordisk A/S buy hoffi69
Summary
This prediction ended on 27.06.12 with a price of €21.82. The BUY prediction by hoffi69 finished with a performance of 5.60%. hoffi69 has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S | - | - | - | - |
| iShares Core DAX® | 0.051% | 5.593% | 14.403% | 19.767% |
| iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% | 57.237% |
| iShares Nikkei 225® | 2.181% | 2.815% | 11.116% | 8.873% |
| iShares S&P 500 | 1.040% | 4.975% | 27.631% | 48.786% |
Comments by hoffi69 for this prediction
In the thread Novo Nordisk A/S diskutieren
Megatrend
Die Aktie von Novo Nordisk befindet sich seit Jahren in einem konstanten Aufwärtstrend-und es gibt kein wirkliches Argument,warum sich dieser nicht auch künftig fortsetzten sollte.Im Gegenteil,Diabetes-Medikamente(Insulin),wie sie von Novo Nordisc vertrieben werden,werden weiterhin ein Megatrend bleiben.Die "Zivilisationskrankheiten"lassen grüßen...